A handful of lubricant eye ointments have been voluntarily recalled after the manufacturer, Brassica Pharma, noted that their facility lacked proper sterilization processes.
The recall comes after the U.S. Food and Drug Administration reported insufficient sterilization during a recent inspection of the manufacturing facility. However, the FDA’s February 26 report did not provide details about the specific sterilization lapses discovered during the inspection.





